文献速递造血干细胞移植与细胞治疗

单细胞免疫图谱揭示诱导胃肠道移植物抗宿主病的发育上独特的CD4+ GM-CSF+ T细胞谱系

Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD.
PubMed 文献 · Blood Adv · 2022-01-01

该研究利用单细胞RNA测序分析,在移植物抗宿主病(GVHD)期间鉴定出两群CD4+ GM-CSF+ T细胞,依据干扰素-γ(IFN-γ)共表达与否区分。CD4+ GM-CSF+ IFN-γ- T细胞优先出现于结肠,具有独特转录谱、基因调控网络和T细胞受体库,其致病作用依赖白细胞介素-17(IL-7)受体信号而不依赖1型干扰素信号。

要点

  • GVHD期间存在两群CD4+ GM-CSF+ T细胞,按IFN-γ共表达与否可区分。
  • CD4+ GM-CSF+ IFN-γ- T细胞优先在结肠出现,转录谱与T细胞受体库独特。
  • 该群细胞致胃肠道病理损伤依赖IL-7受体信号,不依赖1型干扰素信号。

核心结论

  • 研究揭示了GVHD期间CD4+ GM-CSF+ T细胞的异质性,并定义了一个发育上独特的致结肠炎性T辅助亚群GM-CSF+亚型,该亚群介导免疫病理。

研究设计与样本

  • 采用单细胞RNA测序分析(scRNAseq)对GVHD期间出现的CD4+ GM-CSF+ T细胞群进行研究。

主要发现

  • 鉴定出两群CD4+ GM-CSF+ T细胞,依据干扰素-γ(IFN-γ)共表达与否可区分。
  • CD4+ GM-CSF+ IFN-γ- T细胞优先出现于结肠,具有独特转录谱、使用独特基因调控网络,且与CD4+ GM-CSF+ IFN-γ+ T细胞及结肠中所有其他转录定义的CD4+ T细胞群相比具有不重叠的T细胞受体库。
  • 该CD4+ GM-CSF+ T细胞群参与胃肠道病理损伤,该作用关键依赖于白细胞介素-17(IL-7)受体信号,但不依赖1型干扰素信号。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gastrointestinal (GI) tract involvement is a major determinant for subsequent morbidity and mortality arising during graft-versus-host disease (GVHD). CD4+ T cells that produce granulocyte-macrophage colony stimulating factor (GM-CSF) have emerged as central mediators of inflammation in this tissue site as GM-CSF serves as a critical cytokine link between the adaptive and innate arms of the immune system. However, cellular heterogeneity within the CD4+ GM-CSF+ T-cell population due to the concurrent production of other inflammatory cytokines has raised questions as to whether these cells have a common ontology or if a unique CD4+ GM-CSF+ subset exists that differs from other defined T helper subtypes. Using single-cell RNA sequencing analysis (scRNAseq), we identified two CD4+ GM-CSF+ T-cell populations that arose during GVHD and were distinguishable according to the presence or absence of interferon-γ (IFN-γ) coexpression. CD4+ GM-CSF+ IFN-γ- T cells, which emerged preferentially in the colon, had a distinct transcriptional profile, used unique gene regulatory networks, and possessed a nonoverlapping T-cell receptor repertoire compared with CD4+ GM-CSF+ IFN-γ+ T cells as well as all other transcriptionally defined CD4+ T-cell populations in the colon. Functionally, this CD4+ GM-CSF+ T-cell population contributed to pathologic damage in the GI tract that was critically dependent on signaling through the interleukin-17 (IL-7) receptor but was independent of type 1 interferon signaling. Thus, these studies help to unravel heterogeneity within CD4+ GM-CSF+ T cells that arise during GVHD and define a developmentally distinct colitogenic T helper subtype GM-CSF+ subset that mediates immunopathology.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Piper C, Hainstock E, Yin-Yuan C, et al. Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD. Blood Adv. 2022. PMID: 35015822. doi:10.1182/bloodadvances.2021006084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。